Montironi R - Search Results

1

Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.

Carrozza F, Santoni M, Piva F, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R, Battelli N, Tamberi S. Carrozza F, et al. Among authors: montironi r. Crit Rev Oncol Hematol. 2018 Nov;131:1-6. doi: 10.1016/j.critrevonc.2018.07.008. Epub 2018 Aug 1. Crit Rev Oncol Hematol. 2018. PMID: 30293699 Free article. Review.

2

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.

Lopez-Beltran A, Cheng L, Andersson L, Brausi M, de Matteis A, Montironi R, Sesterhenn I, van det Kwast KT, Mazerolles C. Lopez-Beltran A, et al. Among authors: montironi r. Virchows Arch. 2002 Jan;440(1):3-11. doi: 10.1007/s00428-001-0577-6. Virchows Arch. 2002. PMID: 11942574 Review.

3

Evaluation of prognostic factors in radical prostatectomy specimens with cancer.

Mazzucchelli R, Santinelli A, Lopez-Beltran A, Scarpelli M, Montironi R. Mazzucchelli R, et al. Among authors: montironi r. Urol Int. 2002;68(4):209-15. doi: 10.1159/000058437. Urol Int. 2002. PMID: 12053019 Review.

4

Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network.

Montironi R, Mazzucchelli R, Colanzi P, Streccioni M, Scarpelli M, Thompson D, Bartels PH. Montironi R, et al. Eur Urol. 2002 Apr;41(4):449-57. doi: 10.1016/s0302-2838(02)00028-3. Eur Urol. 2002. PMID: 12074818

5

Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention.

Montironi R, Mazzucchelli R, Scarpelli M. Montironi R, et al. Ann N Y Acad Sci. 2002 Jun;963:169-84. doi: 10.1111/j.1749-6632.2002.tb04108.x. Ann N Y Acad Sci. 2002. PMID: 12095942

6

Molecular techniques and prostate cancer diagnostic.

Montironi R, Mazzucchelli R, Scarpelli M. Montironi R, et al. Eur Urol. 2003 Oct;44(4):390-400. doi: 10.1016/s0302-2838(03)00309-9. Eur Urol. 2003. PMID: 14499671 Review.

7

Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma.

Montironi R, Scarpelli M, Mazzucchelli R, Hamilton PW, Thompson D, Ranger-Moore J, Bostwick DG, Bartels PH. Montironi R, et al. Hum Pathol. 2003 Sep;34(9):893-901. doi: 10.1016/s0046-8177(03)00341-1. Hum Pathol. 2003. PMID: 14562285

8

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018. Eur Urol. 2004. PMID: 15036668 Review.

9

Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors.

Montironi R, Scarpelli M, López Beltran A. Montironi R, et al. Virchows Arch. 2004 Jun;444(6):503-8. doi: 10.1007/s00428-004-0996-2. Epub 2004 Mar 26. Virchows Arch. 2004. PMID: 15045584 Review.

10

Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia.

Montironi R, Thompson D, Scarpelli M, Mazzucchelli R, Peketi P, Hamilton PW, Bostwick DG, Bartels PH. Montironi R, et al. Mod Pathol. 2004 Aug;17(8):928-37. doi: 10.1038/modpathol.3800142. Mod Pathol. 2004. PMID: 15105811 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,022 results

Search Page

Filters